This important and compelling study establishes a robust computational and experimental framework for the large-scale identification of metallophore biosynthetic clusters. The work advances beyond ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...
Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug ...
In conjunction Company provides guidance on Fiscal 2025 billings and corporate update Ottawa, Ontario–(Newsfile Corp. –) – DEFSEC Technologies Inc. (TSXV: DFSC) (TSXV: ...
Lumafield, the leader in industrial X-ray CT technology, today announced Auto-Dimensioning, a robust new capability that provides engineers with easy, automated methods for Geometric Dimensioning and ...
Investors, analysts and other interested parties may access Acadian Timber Corp.’s 2025 Third Quarter Results conference call and webcast on ...
Koryx Copper Inc. ("Koryx" or the "Company") is pleased to announce assay results from 17 drill holes (5,556m) received as part of the Phase 2 and 3 drill program for its 2025 exploration and project ...
ATCO Ltd. ATCO Structures today announced that its U.S. division, ATCO Structures & Logistics (USA) Inc., has been awarded a contract to design, supply and install a worker housing facility for ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...
In a major conflict of interest, FMinus study shows nation’s climate action taking a back seat to Big Oil’s lobbying playbook ...
Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging ...
DnaK/DnaJ or Trigger factor and find that chaperone dependence during primary biogenesis in vivo does not track with ...